Article info
Original research
Validity of the COmprehensive Score for financial Toxicity (COST) in patients with gynecologic cancer
- Correspondence to Yusuke Kajimoto, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan; ykajimoto234{at}gmail.com
Citation
Validity of the COmprehensive Score for financial Toxicity (COST) in patients with gynecologic cancer
Publication history
- Received January 22, 2022
- Accepted April 5, 2022
- First published April 20, 2022.
Article Versions
- You are currently viewing a Previous version of this article (6 September 2022).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.